No TGA-approved pharmacy can dispense it
In its phase 3 TRIUMPH-4 study, the company reported that its new triple-agonist injection, retatrutide, produced an average 28.7% reduction in body weight over 68 weeks a result that surpasses even the blockbuster Zepbound
This professional oversight provides safety, accountability, and the best chance for lasting success
The endogenous and engineered disulfide bonds are shown with solid and dashed orange lines, respectively
If youre reading this, chances are youor someone you care aboutis looking into testosterone replacement therapy (TRT) with hopes of fixing something that feels off
These typically peak when you start treatment or youre stepping up your doses (titration) and improve as your body adjusts: Because Retatrutide also targets glucagon, this alters how it affects your body, resulting in a couple of side effects not usually seen with Zepbound: 1